|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 616.45 USD | +1.32% |
|
+0.55% | +9.76% |
| Capitalization | 17.36B 14.9B 13.87B 12.91B 24.09B 1,568B 25.97B 160B 62.75B 750B 65.12B 63.78B 2,748B | P/E ratio 2025 * |
41.6x | P/E ratio 2026 * | 37.4x |
|---|---|---|---|---|---|
| Enterprise value | 16.96B 14.55B 13.55B 12.61B 23.53B 1,531B 25.37B 156B 61.29B 732B 63.61B 62.3B 2,684B | EV / Sales 2025 * |
6.75x | EV / Sales 2026 * | 5.8x |
| Free-Float |
83.69% | Yield 2025 * |
-
| Yield 2026 * | - |
Last Transcript: Medpace Holdings, Inc.
| 1 day | +1.32% | ||
| 1 week | +0.55% | ||
| Current month | +9.76% | ||
| 1 month | +10.49% | ||
| 3 months | +19.25% | ||
| 6 months | +92.42% | ||
| Current year | +9.76% |
| 1 week | 591.36 |  | 619.3 |
| 1 month | 544.24 | | 619.3 |
| Current year | 551 | | 619.3 |
| 1 year | 250.05 | | 626.26 |
| 3 years | 167 | | 626.26 |
| 5 years | 126.94 | | 626.26 |
| 10 years | 21.76 | | 626.26 |
| Manager | Title | Age | Since |
|---|---|---|---|
August Troendle
CEO | Chief Executive Officer | 69 | 01/07/1992 |
Kevin Brady
DFI | Director of Finance/CFO | 51 | 01/08/2021 |
Jesse Geiger
PSD | President | 51 | 01/08/2021 |
| Director | Title | Age | Since |
|---|---|---|---|
August Troendle
CHM | Chairman | 69 | 01/07/1992 |
Robert Kraft
BRD | Director/Board Member | 55 | 01/07/2016 |
Brian Carley
BRD | Director/Board Member | 72 | 01/07/2016 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.32% | +0.55% | +86.29% | +169.71% | 17.36B | |
| +1.02% | +1.85% | +3.31% | +11.95% | 49.05B | |
| -0.09% | -1.20% | +21.92% | +8.65% | 41.1B | |
| -1.23% | +3.86% | +72.52% | +28.11% | 38.37B | |
| -4.30% | +0.24% | +19.22% | +36.66% | 31.59B | |
| +1.06% | +18.02% | +204.34% | +302.86% | 23.43B | |
| +8.08% | -33.49% | +27,398.05% | +4,371.14% | 17.39B | |
| -0.36% | +4.18% | +54.81% | +10.54% | 14.83B | |
| +0.81% | -8.94% | -7.73% | -17.69% | 14.11B | |
| +1.06% | +1.89% | +65.17% | +88.92% | 13.34B | |
| Average | +0.74% | -1.41% | +2,791.79% | +501.08% | 26.06B | |
| Weighted average by Cap. | +0.27% | -0.14% | +1,875.81% | +346.67% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 2.51B 2.15B 2.01B 1.87B 3.48B 227B 3.76B 23.07B 9.07B 108B 9.42B 9.22B 397B | 2.81B 2.41B 2.25B 2.09B 3.9B 254B 4.21B 25.84B 10.17B 121B 10.55B 10.33B 445B |
| Net income | 436M 374M 348M 324M 605M 39.37B 652M 4.01B 1.58B 18.83B 1.64B 1.6B 69.02B | 479M 411M 383M 356M 665M 43.28B 717M 4.4B 1.73B 20.71B 1.8B 1.76B 75.87B |
| Net Debt | -404M -347M -323M -300M -561M -36.49B -604M -3.71B -1.46B -17.45B -1.52B -1.48B -63.95B | -1.06B -910M -848M -789M -1.47B -95.76B -1.59B -9.74B -3.83B -45.81B -3.98B -3.9B -168B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 14/01/26 | 616.45 $ | +1.32% | 196,117 |
| 13/01/26 | 608.43 $ | +1.54% | 264,983 |
| 12/01/26 | 599.21 $ | +0.71% | 274,566 |
| 09/01/26 | 595.00 $ | -0.84% | 189,214 |
| 08/01/26 | 600.02 $ | -2.13% | 235,707 |
Delayed Quote Nasdaq, January 15, 2026 at 05:00 am
More quotes
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- MEDP Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition